37 citations as recorded by crossref.

1. Suppressive Antibiotic Treatment in Prosthetic Joint Infections: A Perspective J. Cobo & R. Escudero-Sanchez https://doi.org/10.3390/antibiotics10060743
2. Antibiotics with antibiofilm activity – rifampicin and beyond L. Ferreira et al. https://doi.org/10.3389/fmicb.2024.1435720
3. Dosing and treatment duration of suppressive antimicrobial therapy in orthopedic implant infections: a cohort study J. Hanssen et al. https://doi.org/10.5194/jbji-9-149-2024
4. Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic Choice M. Gatti et al. https://doi.org/10.3390/antibiotics11030406
5. Long-Term Outcomes Following Suppressive Antibiotic Therapy: A 10-Year Cohort Study R. George et al. https://doi.org/10.3390/antibiotics14111164
6. Diagnosis and management of infected arthroplasty T. Pannu et al. https://doi.org/10.1051/sicotj/2021054
7. Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety A. Ruiz-Sancho et al. https://doi.org/10.3389/fphar.2023.1185602
8. Reinfection and re-revision rates of 113 two-stage revisions in infected TKA J. Bongers et al. https://doi.org/10.7150/jbji.43705
9. Characterization of Methicillin-Resistant Staphylococcus aureus Isolates from Periprosthetic Joint Infections J. Chen et al. https://doi.org/10.3390/pathogens11070719
10. Safety of Longer-Term Doxycycline Use: A Systematic Review and Meta-Analysis With Implications for Bacterial Sexually Transmitted Infection Chemoprophylaxis P. Chan et al. https://doi.org/10.1097/OLQ.0000000000001865
11. Prevention and antibiotic therapy of hip periprosthetic joint infections F. GIOVANNENZE et al. https://doi.org/10.23736/S2784-8469.21.04185-7
12. Results of Aspiration, Erythrocyte Sedimentation Rate, and C-Reactive Protein in Patients With Known Prosthetic Joint Infection on Chronic Suppression M. Benson et al. https://doi.org/10.5435/JAAOSGlobal-D-25-00139
13. Rifampicin in Osteoarticular Infections: A Comprehensive Review of Current Evidence F. Laurent & J. Yombi https://doi.org/10.3390/antibiotics15090872
14. Oral tetracyclines for bone and joint infections: what do we know? T. Cartau et al. https://doi.org/10.5194/jbji-10-143-2025
15. Periprosthetic Joint Infection R. Miller et al. https://doi.org/10.2106/JBJS.RVW.19.00224
16. Rôle des CRIOAC : quand faire appel à un CRIOAC ? Stratégie thérapeutique, principes de l’antibiothérapie H. Migaud et al. https://doi.org/10.1016/j.rcot.2025.11.003
17. Periprosthetic joint infection after arthroplasty: advances and future prospects X. Xiong et al. https://doi.org/10.1186/s13018-025-06257-2
18. Efficacy and Safety of Tetracyclines in Bone and Joint Infections: A Literature Review P. Laffont-Lozes et al. https://doi.org/10.1007/s40121-026-01324-5
19. Biofilm and How It Relates to Prosthetic Joint Infection A. MacConnell et al. https://doi.org/10.1016/j.ocl.2023.10.001
20. The Role of Tetracyclines in Joint Arthroplasties K. Passadi et al. https://doi.org/10.24018/ejmed.2024.6.4.2145
21. Global practice variation of suppressive antimicrobial treatment for prosthetic joint infections: A cross-sectional survey study J. Hanssen et al. https://doi.org/10.1016/j.jinf.2024.106316
22. Long-Term Impact of Suppressive Antibiotic Therapy on Intestinal Microbiota R. Escudero-Sánchez et al. https://doi.org/10.3390/genes12010041
23. Outcomes of Long-Term Antibiotic Therapy for Prosthetic Joint Infection: A Cohort Study in a Canadian High-Volume Arthroplasty Center C. Righolt et al. https://doi.org/10.1016/j.artd.2025.101789
24. Clinical use of linezolid in periprosthetic joint infections – a systematic review C. Theil et al. https://doi.org/10.5194/jbji-6-7-2020
25. The Application of Suppressive Antibiotic Therapy for Implant-Related Infection X. Wu et al. https://doi.org/10.1093/cid/ciaf002
26. Implant-Associated Infection of Long-Segment Spinal Instrumentation: A Retrospective Analysis of 46 Consecutive Patients S. Oikonomidis et al. https://doi.org/10.31616/asj.2019.0391
27. The Use of Long-term Antibiotics for Suppression of Bacterial Infections M. Horne et al. https://doi.org/10.1093/cid/ciae302
28. Resektionsarthroplastik und Arthrodese in der Prothesenrevision O. Somberg et al. https://doi.org/10.1007/s00132-022-04340-8
29. Polymicrobial periprosthetic joint infections of the hip and knee D. Margaryan et al. https://doi.org/10.1302/0301-620X.107B12.BJJ-2024-1656.R2
30. Long-Term Outcomes in Patients on Life-Long Antibiotics: A Five-Year Cohort Study C. Kiss et al. https://doi.org/10.3390/antibiotics11010062
31. 2025 ICM: Antimicrobial Therapy Options in Special Circumstances M. Karim et al. https://doi.org/10.1016/j.arth.2025.10.084
32. Outcome of guided persistent fistula as a salvage procedure in patients with chronic periprosthetic joint infection R. Samargandi et al. https://doi.org/10.1007/s00264-026-06963-4
33. Debridement, antibiotics and implant retention: are all approaches to periprosthetic joint infection equal? Same procedures, different outcomes P. Sendi et al. https://doi.org/10.1016/j.cmi.2025.04.037
34. Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin P. Reinecke et al. https://doi.org/10.3390/antibiotics12111560
35. Adverse events and tolerability of long-term suppressive antibiotic therapy for periprosthetic joint infection: a prospective cohort study P. Reinecke et al. https://doi.org/10.5194/jbji-11-267-2026
36. Complications of Hip Hemiarthroplasty G. Domingue et al. https://doi.org/10.3928/01477447-20230125-06
37. Suppressive Antibiotic Therapy in Prosthetic Joint Infections: A Contemporary Overview H. Harrabi et al. https://doi.org/10.3390/antibiotics14030277